版本:
中国

BRIEF-Galena Biopharma Inc presents preclinical Neuvax data in Ovarian and Pancreatic cancer

Sept 13 (Reuters) -

* Galena Biopharma Inc says presents preclinical Neuvax data in Ovarian and Pancreatic cancer

* Galena Biopharma Inc says administration of Neuvax vaccination resulted in a specific, delayed type hypersensitivity reaction

* Both Ovarian and Pancreatic tumor growth rate was significantly reduced in NSG mice that received CD8+ T cells from Neuvax-immunized mice Source text for Eikon:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐